CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
- Operating income, 2025
- −$665M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$665M | — |
| 2024 | −$467M | — |
| 2023 | −$223M | — |
| 2022 | −$673M | — |
| 2021 | $374M | — |
| 2020 | −$354M | — |
| 2019 | $47M | — |
| 2018 | −$159M | — |
| 2017 | −$65M | — |
| 2016 | −$68M | — |
| 2015 | −$26M | — |
| 2014 | −$6.6M | — |